These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6781788)

  • 21. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
    J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale production of hepatitis B vaccine.
    Funakoshi S; Ohmura T; Fujiwara T; Suyama T; Naito R
    Prog Med Virol; 1981; 27():163-7. PubMed ID: 7232759
    [No Abstract]   [Full Text] [Related]  

  • 23. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis B virus vaccine and genetic engineering].
    Koike K
    Nihon Rinsho; 1982; 40(8):1818-25. PubMed ID: 6755001
    [No Abstract]   [Full Text] [Related]  

  • 25. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Safety of hepatitis B vaccine].
    Dtsch Med Wochenschr; 1983 May; 108(19):754-5. PubMed ID: 6840003
    [No Abstract]   [Full Text] [Related]  

  • 28. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis B vaccine trial in healthy adults - an immunogenicity study (author's transl)].
    Zachoval R; Frösner G; Deinhardt F
    MMW Munch Med Wochenschr; 1981 Oct; 123(40):1506-8. PubMed ID: 6795461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electron and immunoelectron microscopic study of Dane particle formation in chronic hepatitis B virus infection.
    Yamada G; Sakamoto Y; Mizuno M; Nishihara T; Kobayashi T; Takahashi T; Nagashima H
    Gastroenterology; 1982 Aug; 83(2):348-56. PubMed ID: 7084614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major polypeptide of duck hepatitis B surface antigen particles.
    Marion PL; Knight SS; Feitelson MA; Oshiro LS; Robinson WS
    J Virol; 1983 Nov; 48(2):534-41. PubMed ID: 6620467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Humoral immunological studies in viral hepatitis and in HBAg virus carriers].
    Vu BD
    Orv Hetil; 1978 May; 119(22):1339-44. PubMed ID: 652352
    [No Abstract]   [Full Text] [Related]  

  • 37. [HBs-positive periarteritis nodosa].
    Rouget JP; Warembourg A; Dessaint JP; Dewailly P; Jaillard J
    LARC Med; 1984 Mar; 4(3):153-6. PubMed ID: 6144021
    [No Abstract]   [Full Text] [Related]  

  • 38. The development of a vaccine against hepatitis B.
    Krugman S
    Scand J Infect Dis Suppl; 1983; 38():9-12. PubMed ID: 6580728
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on hepatitis B virus antigens. I. Separation of hepatitis B surface antigen (HBsAg) from human plasma and heterogeneity of the polypeptides in the antigen.
    Liu WT; Kao WY; Lu CC
    Taiwan Yi Xue Hui Za Zhi; 1982 Jan; 81(1):18-30. PubMed ID: 6178790
    [No Abstract]   [Full Text] [Related]  

  • 40. The preparation and safety of hepatitis B vaccine.
    Hilleman MR; McAleer WJ; Buynak EB; McLean AA
    J Infect; 1983 Jul; 7 Suppl 1():3-8. PubMed ID: 6674367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.